NHNaohito Hato

Naohito Hato

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Naohito Hato has a total of 116 co-authors. Here are the top co-authors by number of shared publications:

  • Kiyofumi Gyo

    Department of Otolaryngology, Ehime University School of Medicine, Ehime, Japan

    13 shared publications
  • Hiroyuki Yamada

    Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Ehime University

    7 shared publications
  • Naoaki Yanagihara

    Department of Otolaryngology, Ehime University School of Medicine, Ehime, Japan

    7 shared publications
  • Hirotaka Takahashi

    Department of Otolaryngology, Takanoko Hospital, Matsuyama, Ehime, Japan

    6 shared publications
  • Masahiro Okada

    5 shared publications
  • Nobuhiro Hakuba

    Department of Otolaryngology, Ehime University School of Medicine, Shitsukawa, To-on City, Ehime, Japan

    5 shared publications

Latest Publications

  • Open Access

    Development and validation of an electrosurgery-compatible simulation task for quantitatively assessing oral cancer resection skills

    by Kayo Sakamoto, Sohei Mitani, Naoki Nishio, Takashi Kitani, Eriko Sato, Keiko Tanaka, Toru Ugumori, Hiroyuki Wakisaka, Naohito Hato

    Background The quality of oral cancer resection is extremely important for patient outcomes, such as local control and survival. However, most current simulators either provide only subjective feedback or are not compatible with electrosurgery. Therefore, we developed an electrosurgical simulation task for oral cancer resection that provides quantitative metrics and investigated its validity. Methods We developed a soft tissue simulation task using a plant-derived model that supports electrosurgery. As quantitative measures demonstrating “ensuring appropriate margins” in oral cancer resection and “maintaining safety” during electrosurgery, we employed nine-directional margin error distance and tumor bed carbonization degree measured using a spectral colorimeter. As validity evidence of the task, 10 expert surgeons completed a questionnaire about the task. In addition, five experts and 12 novices performed the task, and quantitative data obtained from their performance was used for evaluation. Results The replication of oral cancer resection was highly evaluated (4.4 out of 5 points), and quantitative measures for evaluating the skills of surgeons (4.8 out of 5 points) were agreed upon by experts. The internal consistency of the measures was good (Cronbach's alpha: 0.803). Compared to novices, experts had smaller margin errors (0.79 mm vs 2.45 mm), lower carbonization (ΔE: 2.33 vs 8.70), faster resection times, and fewer grasping attempts (all P < 0.0001). Conclusion This user-friendly plant-derived simulation task is compatible with electrosurgery and can quantitatively assess proficiency in oral cancer resection. Using this task is expected to promote early acquisition of tumor resection skills and improve oncological safety.

  • Spontaneous Sublingual Space Hematoma: A Rare Cause of Upper Airway Obstruction

    by Yasunori Abe, Souhei Mitani, Naohito Hato

    特発性舌下間隙血腫は非常に稀な疾患であるが,気道閉塞をきたす危険性が高く,気道管理が非常に重要な疾患である。今回,特発性舌下間隙血腫の1例を経験したので報告する。症例は60歳代後半の女性で当院内科に成人T細胞白血病リンパ腫 (ATLL) の終末期として入院中であった。症状緩和目的のステロイドでのハーフパルス療法後より咽頭痛,嚥下困難感,口腔内出血を認めたため当科紹介受診した。当科初診時,舌根部に粘膜下血腫による腫脹を認めたが,気道は保たれていた。画像検査から舌下間隙血腫と診断し,4時間後に再度確認したところ血腫は明らかに増大しており,造影CTでその中央部に出血点と思われる造影剤の漏出を認めたため,気管切開と止血,血腫除去術を施行した。術後,血腫は消退傾向を示していたが,術後3日目よりATLLの中枢浸潤と考えられる意識レベルの低下を認め,術後14日目に永眠された。特発性舌下間隙症例に対して,気道に注意して経過をみることで比較的安全に気道確保を行うことができた。出血と血腫に対しては,危険因子に対する治療を行うことで軽快することが多いが,合併症には注意が必要である。

  • A Clinical Study of Inspiratory Stridor in Infants

    by Kaori Tanaka, Naoya Nishida, Hiroyuki Yamada, Naohito Hato

    当科における乳幼児吸気時喘鳴症例について検討を行った。原因は,従来の報告同様喉頭軟弱症が最も多く,そのうち21.4%では声帯運動障害や舌根嚢胞等,他の気道狭窄所見(secondary airway lesions: SALs)を合併していた。SALsは喘鳴の重症度や予後にも影響するため,重症例やSALsを疑う症例では,外来での喉頭内視鏡検査に加え,全身麻酔下喉頭直達鏡検査等を追加して正確な診断を行う必要がある。また背景疾患,挿管歴,低出生体重はrisk factorであった。問診では,これらの既往に加えて喘鳴タイプ(吸気性/呼気性/二相性,急性/慢性)や発症時期,喘鳴を生じる場面や程度,嚥下障害の有無等を十分に把握することが適切な診断および治療法選択には不可欠である。乳幼児は解剖学的・生理学的に気道狭窄をきたしやすく,短期間で重篤になりやすい特徴があることを認識し,迅速な診断かつ対応を行う必要がある。

  • A Study of Cases of Cervical Neurinoma Surgery

    by Sohei Mitani, Toru Ugumori, Hinako Kawamoto, Tomoyoshi Sanada, Junpei Nota, Hiroyuki Wakisaka, Naohito Hato

  • Prevention of ischemia-induced hearing loss by intravenous administration of hydrogen-rich saline in gerbil

    by Hideo Ogawa, Masahiro Okada, Masachika Shudou, Kiyofumi Gyo, Naohito Hato


  • A Case of Sudden Sensorineural Hearing Loss Associated with Phosphodiesterase Type 5 Inhibitors

    by Yuji Hayashi, Masahiro Okada, Hiroyuki Yamada, Naohito Hato

    The phosphodiesterase type 5 (PDE5) inhibitors —sildenafil, vardenafil and tadalafil— are used in the treatment of erectile dysfunction, pulmonary hypertension and benign prostatic hyperplasia (BPH). Recently, hearing loss associated with PDE5 inhibitor use has been reported. We report a patient who developed unilateral sudden hearing loss possibly related to the use of tadalafil. This is the first case report of sudden sensorineural hearing loss related to the use of a PDE5 inhibitor drug in Japan. A 64-year-old male was started on treatment with tadalafil for BPH. Eight days after the start of treatment, the patient developed sudden right-sided hearing loss. He was referred our hospital, as his hearing did not recover despite oral prednisolone treatment (PSL 40 mg/day for 5 days) prescribed by an ENT specialist. An audiogram revealed sensorineural hearing loss in the right ear, with normal hearing in the other ear. DP-OAE elicited no responses in the right ear. The patient had no tinnitus or disequilibrium, and no nystagmus was observed. The patient was restarted on prednisolone (60 mg/day), which was administered for three days, with the dose tapered over 9 days and discontinuation of tadalafil. An audiogram after the corticosteroid therapy showed complete recovery of the hearing on the right side. The acute sensorineural hearing loss in this patient was probably caused by the ototoxic effects of the PDE5 inhibitor drug.

  • Elevated Na + /H + exchanger-1 expression enhances the metastatic collective migration of head and neck squamous cell carcinoma cells

    by Teppei Kaminota, Hajime Yano, Kohei Shiota, Noriko Nomura, Haruna Yaguchi, Yui Kirino, Kentaro Ohara, Issei Tetsumura, Tomoyoshi Sanada, Toru Ugumori, et al.


  • Facial paralysis induced by ear inoculation of herpes simplex virus in rat

    by Takashi Fujiwara, Seiji Matsuda, Junya Tanaka, Naohito Hato


  • Efficacy of chlorophyll c2 for seasonal allergic rhinitis: single-center double-blind randomized control trial

    by Takashi Fujiwara, Naoya Nishida, Jumpei Nota, Takashi Kitani, Kunihide Aoishi, Hirotaka Takahashi, Takuya Sugahara, Naohito Hato

    Chlorophyll c2 extracted from Sargassum horneri improved allergic symptoms in an animal model of allergic rhinitis. In the present study, we explored the efficacy of chlorophyll c2 in patients with seasonal allergic rhinitis. This was a single-center, randomized, double-blind placebo-controlled trial. Sixty-six patients aged 20–43 years, each with a 2-year history of seasonal allergic rhinitis, were randomly assigned to receive either a single daily dose (0.7 mg) of chlorophyll c2 or placebo for 12 weeks. The use of medications including H1-antihistamines and topical nasal steroids was recorded by rescue medication scores (RMSs) noted after 4, 8, and 12 weeks of treatment. Disease-specific quality of life was measured using the Japan Rhinitis Quality of Life Questionnaire (JRQLQ) both before and after 4, 8, and 12 weeks of treatment. The RMS at 8 weeks was significantly better in the chlorophyll c2 than the placebo group (mean RMS difference = −3.09; 95 % confidence interval = −5.96 to −0.22); the mean RMS at 4 weeks was only slightly better in the chlorophyll c2 group. The JRQLQ scores did not differ significantly between the two groups. Chlorophyll c2 would have a potential to be an alternative treatment for allergic rhinitis.